INPP5D and pachyonychia congenita: Our previous in vivo studies have shown that apigenin treatment in experimental models of PC induces anti-tumor immune responses by depleting proinflammatory TDFs, MDSC and protumor M2-TAM as well as upregulating tumoricidal M1 TAM and SHIP-1 expression in the tumors from mice [12,55].